<p>In this episode of the <a style= "color: #00a9f6; text-decoration: none;" href= "https://www.avalere.com" target="_blank" rel= "noopener">Avalere</a> Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.</p>

In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.

<p>In this episode of the <a href="https://www.avalere.com" rel="noopener noreferrer">Avalere</a> Health Essential Voice Disease Education series, our experts discuss value-based payment arrangements in cell and gene therapies and the role they play in facilitating access to these products.</p>

Cell and Gene Therapy in Oncology, Part II

Twenty years ago, Avalere set out to be the essential voice in improving healthcare. Rest your eyes or use your commute time to listen to our experts discuss the hot topics that you need to track.

Share Cell and Gene Therapy in Oncology, Part II

Sign up to save your podcasts

Cell and Gene Therapy in Oncology, Part II

Cell and Gene Therapy in Oncology, Part II